Procter & Gamble Hygiene & Health Care Ltd.
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods in the feminine care and healthcare businesses in India and internationally. It operates through Health care Products and Hygiene Products segments. The company offers health care products, including ointments and creams, cough drops, and tablets; and hygiene products, such as feminine hygiene and other skin care hygiene products, as well as feminine care pads. It also provides baby care products comprising nappies, pants, and baby wipes; grooming products; laundry products; hair care products; home, personal and skin care, and oral products. The company sells its products under the Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Olay, and Old Spice brands through mass merchandisers, as well as grocery, membership club, drug, department, and high frequency stores. The company was incorporated in 1964 and is based in Mumbai, India. Procter & Gamble Hygiene and Health Care Limited operates as a subsidiary of The Procter & Gamble Company.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockRule-based from financial data. Not advice.
Historically, Sep has averaged the highest return (+4.3%); Mar the lowest (-3.9%).
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -8.9%Negative MonthJan 2026: -8.94% | -3.6%Negative MonthFeb 2026: -3.62% | -17.9%Negative MonthMar 2026: -17.88% | +8.8%Positive MonthApr 2026: +8.82% | -4.8%Negative MonthMay 2026: -4.77% | -6.5%Negative MonthJun 2026: -6.53% | -0.7%*Neutral MonthJul 2026: -0.73% | β | β | β | β | β |
| 2025 | -1.6%Neutral MonthJan 2025: -1.56% | -6.6%Negative MonthFeb 2025: -6.60% | +0.5%Neutral MonthMar 2025: +0.51% | +4.4%Positive MonthApr 2025: +4.42% | -4.3%Negative MonthMay 2025: -4.31% | -1.7%Neutral MonthJun 2025: -1.66% | +2.7%Positive MonthJul 2025: +2.72% | -4.6%Negative MonthAug 2025: -4.63% | +7.9%Positive MonthSep 2025: +7.92% | -5.6%Negative MonthOct 2025: -5.56% | -4.5%Negative MonthNov 2025: -4.50% | +1.5%Neutral MonthDec 2025: +1.51% |
| 2024 | -1.2%Neutral MonthJan 2024: -1.25% | -8.5%Negative MonthFeb 2024: -8.46% | +7.7%Positive MonthMar 2024: +7.66% | -4.8%Negative MonthApr 2024: -4.78% | -0.3%Neutral MonthMay 2024: -0.35% | +3.7%Positive MonthJun 2024: +3.72% | +1.7%Neutral MonthJul 2024: +1.72% | -2.4%Negative MonthAug 2024: -2.35% | +0.9%Neutral MonthSep 2024: +0.87% | -3.1%Negative MonthOct 2024: -3.09% | -1.6%Neutral MonthNov 2024: -1.62% | -7.3%Negative MonthDec 2024: -7.28% |
| 2023 | -2.5%Negative MonthJan 2023: -2.48% | -2.8%Negative MonthFeb 2023: -2.81% | -2.9%Negative MonthMar 2023: -2.94% | +5.1%Positive MonthApr 2023: +5.09% | -3.5%Negative MonthMay 2023: -3.54% | +5.6%Positive MonthJun 2023: +5.63% | +10.5%Positive MonthJul 2023: +10.48% | +1.0%Neutral MonthAug 2023: +1.04% | +12.5%Positive MonthSep 2023: +12.50% | -2.4%Negative MonthOct 2023: -2.41% | -1.9%Neutral MonthNov 2023: -1.93% | +0.9%Neutral MonthDec 2023: +0.92% |
| 2022 | -4.1%Negative MonthJan 2022: -4.10% | +4.7%Positive MonthFeb 2022: +4.70% | -7.0%Negative MonthMar 2022: -6.98% | -2.5%Negative MonthApr 2022: -2.54% | -1.6%Neutral MonthMay 2022: -1.61% | -3.0%Negative MonthJun 2022: -3.05% | +7.8%Positive MonthJul 2022: +7.84% | -3.2%Negative MonthAug 2022: -3.21% | -0.8%Neutral MonthSep 2022: -0.79% | +1.3%Neutral MonthOct 2022: +1.30% | +1.0%Neutral MonthNov 2022: +0.95% | +2.3%Positive MonthDec 2022: +2.32% |
| 2021 | β | β | β | β | β | +1.9%Neutral MonthJun 2021: +1.87% | -4.8%Negative MonthJul 2021: -4.79% | +9.3%Positive MonthAug 2021: +9.33% | +1.1%Neutral MonthSep 2021: +1.09% | +1.1%Neutral MonthOct 2021: +1.11% | +6.2%Positive MonthNov 2021: +6.20% | +2.5%Positive MonthDec 2021: +2.49% |
| AvgΒ±SD |
Each cell is the percentage change in closing price from the end of the prior month to the end of this month. The bottom row shows the average return for that calendar month across the selected years, plus or minus one standard deviation β the range that historically contained roughly two-thirds of outcomes. Past monthly patterns are not a forecast of future returns.
This aggregates every month by calendar position β all Januaries together, all Februaries together, and so on β to show whether a given month has leaned positive or negative historically. βSimpleβ counts each month as +1 or β1. βWeightedβ gives larger moves more influence: +2 above +10%, β2 below β10%. With only 6 years of history for this asset, each monthβs score reflects a small number of observations β read it as a historical tendency, not a reliable seasonal pattern.
This tracks a running tally across the assetβs full price history: each month adds or subtracts based on whether it was positive or negative. A rising line means more positive months than negative so far; a flattening or falling line means recent months have leaned negative. This measures historical month-to-month consistency, not expected future performance.
Year-to-date return is calculated by dividing each dayβs closing price by the price on January 1st of that year (or the assetβs first available price if it began trading mid-year). The custom average line shows the mean YTD return at each calendar day across the selected years. The standard deviation band shows the range within which returns have historically fallen β at 1 SD, roughly two-thirds of years; at 2 SD, roughly 95%. Past year-to-date patterns do not predict future returns. The average and standard deviation band are computed from the year set chosen in βAverage fromβ, which is independent of which year lines are displayed. The current in-progress year is excluded from these calculations, since a partial year is not comparable to complete ones. Election-cycle groupings follow the US presidential calendar and are offered only for US and crypto assets.
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 10 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | β | β | β | β | β | β | β | β |
| Mar 2024 | βΉ4.21 K Cr | β | βΉ675.00 Cr | β | β | β | 7.4% | -0.4% |
| Mar 2023 | βΉ3.92 K Cr | β | βΉ678.00 Cr | β | β | β | 0.4% | 17.7% |
| Mar 2022 | βΉ3.90 K Cr | β | βΉ576.00 Cr | β | β | β | 9.1% | -11.7% |
| Mar 2021 | βΉ3.57 K Cr | β | βΉ652.00 Cr | β | β | β | 19.1% | 50.6% |
| Mar 2020 | βΉ3.00 K Cr | β | βΉ433.00 Cr | β | β | β | 1.9% | 3.3% |
| Mar 2019 | βΉ2.95 K Cr | β | βΉ419.00 Cr | β | β | β | 20.0% | 11.7% |
| Mar 2018 | βΉ2.46 K Cr | β | βΉ375.00 Cr | β | β | β | 5.8% | -13.4% |
| Mar 2017 | βΉ2.32 K Cr | β | βΉ433.00 Cr | β | β | β | 2.0% | 2.6% |
| Mar 2016 | βΉ2.27 K Cr | β | βΉ422.00 Cr | β | β | β | -2.5% | 22.0% |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 9m | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Net Sales | 2,051 | 2,334 | 2,275 | 2,320 | 2,455 | 2,947 | 3,002 | 3,574 | 3,901 | 3,918 | 4,206 | 3,374 | 4,341 |
| Total Expenses | 1,628 | 1,838 | 1,667 | 1,646 | 1,834 | 2,329 | 2,396 | 2,688 | 3,069 | 3,048 | 3,230 | 2,503 | 3,178 |
| EBIT / Operating Profit | 423 | 495 | 608 | 675 | 622 | 618 | 606 | 886 | 832 | 869 | 976 | 871 | 1,162 |
| OPM % | 21 | 21 | 27 | 29 | 25 | 21 | 20 | 25 | 21 | 22 | 23 | 26 | 27 |
| Other Income | 78 | 64 | 85 | 67 | 18 | 45 | 42 | 38 | 23 | 40 | 47 | 37 | 49 |
| Finance Costs | 5 | 6 | 6 | 10 | 5 | 5 | 6 | 6 | 11 | 11 | 27 | 14 | 12 |
| Depreciation & Amortisation | 35 | 53 | 52 | 60 | 52 | 50 | 48 | 48 | 53 | 58 | 56 | 32 | 38 |
| Profit Before Tax | 460 | 501 | 636 | 672 | 582 | 607 | 594 | 870 | 790 | 839 | 939 | 862 | 1,161 |
| Tax % | 34 | 31 | 34 | 36 | 36 | 31 | 27 | 25 | 27 | 19 | 28 | 26 | - |
| Net Profit / PAT | 302 | 346 | 422 | 433 | 375 | 419 | 433 | 652 | 576 | 678 | 675 | 637 | 859 |
| EPS (βΉ) | 93.04 | 106.63 | 130.16 | 133.31 | 115.40 | 129.12 | 133.42 | 200.79 | 177.37 | 208.91 | 207.95 | 196.11 | 264.78 |
| Dividend Payout % | 30 | 28 | 28 | 292 | 35 | 68 | 79 | 157 | 90 | 89 | 123 | 89 | - |
Peer Comparison
Healthcare sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Procter & Gamble Hygiene & Health Care Ltd.this co. | βΉ40.12 K Cr | βΉ3.37 K Cr | 48.50 | 43.15 | 0.00 | -19.8% |
| Sun Pharmaceutical Industries Ltd. | βΉ4.15 L Cr | βΉ23.00 K Cr | 88.70 | 17.43 | 72.30 | 13.5% |
| Divi's Laboratories Ltd. | βΉ1.71 L Cr | βΉ9.20 K Cr | 67.90 | 11.13 | 67.21 | 20.0% |
| Torrent Pharmaceuticals Ltd. | βΉ1.33 L Cr | βΉ9.68 K Cr | 62.50 | 15.76 | 45.64 | 13.5% |
| Cipla Ltd. | βΉ1.17 L Cr | βΉ19.05 K Cr | 22.50 | 3.51 | 19.33 | 14.9% |
| Apollo Hospitals Enterprises Ltd. | βΉ1.05 L Cr | βΉ8.20 K Cr | 75.00 | 11.28 | 54.44 | 12.8% |
| Max Healthcare Institute Limited | βΉ1.00 L Cr | βΉ2.66 K Cr | 144.00 | 11.76 | 96.84 | 13.8% |
| Industry Average | β | βΉ3.29 K Cr | 98.63 | 8.11 | 65.50 | 20.2% |
